Normal prolactin responses in tardive dyskinesia
- PMID: 43550
- DOI: 10.1007/BF00428314
Normal prolactin responses in tardive dyskinesia
Abstract
Tardive dyskinesia has been hypothesized to be caused by a neuroleptic-induced dopamine hypersensitivity in the nigrostriatal system. This study evaluated with dopamine antagonists the possibility that such dopamine hypersensitivity extends to the tuberoinfundibular dopamine (TIDA) system, which regulates, by inhibition, pituitary prolactin secretion. Plasma prolactin concentrations in six patients with tardive dyskinesia were assessed in four conditions: During chronic haloperidol therapy; serially after abrupt haloperidol withdrawal; while unmediated; and in response to an acute dose of 0.5 mg IM haloperidol. In all four conditions, prolactin responses did not differ from those observed in normal subjects and schizophrenic patients without tardive dyskinesia. It is concluded that there is no evidence for post-synaptic dopamine hypersensitivity in the TIDA-pituitary pathway in patients with tardive dyskinesia, consistent with other reports assessing hormonal responses to dopamine agonists in such cases. It is further suggested that neuroleptic-induced dopamine hypersensitivity does not occur in the TIDA-pituitary system in humans, since it was not manifest in these tardive dyskinesia patients who would be thought particularly prone to develop it.
Similar articles
-
Neuroleptic plasma levels and tardive dyskinesia: a possible link?Schizophr Bull. 1980;6(1):4-7. doi: 10.1093/schbul/6.1.4. Schizophr Bull. 1980. PMID: 6102792
-
The effect of neuroleptic discontinuation on psychopathology, involuntary movements, and biochemical measures in patients with persistent tardive dyskinesia.Biol Psychiatry. 1989 Jul;26(3):224-33. doi: 10.1016/0006-3223(89)90034-6. Biol Psychiatry. 1989. PMID: 2568132
-
Possible associations among plasma prolactin levels, tardive dyskinesia, and paranoia in treated male schizophrenics.Biol Psychiatry. 1986 Jun;21(7):632-42. doi: 10.1016/0006-3223(86)90124-1. Biol Psychiatry. 1986. PMID: 2871874
-
Prediction of outcome in first-episode schizophrenia.J Clin Psychiatry. 1993 Mar;54 Suppl:13-7. J Clin Psychiatry. 1993. PMID: 8097192 Review.
-
The effect of chronic neuroleptic administration on cerebral dopamine receptor function.Life Sci. 1983 May 16;32(20):2289-311. doi: 10.1016/0024-3205(83)90759-2. Life Sci. 1983. PMID: 6133203 Review.
Cited by
-
3H-spiperone binding sites in post-mortem brains from schizophrenic patients: relationship to neuroleptic drug treatment, abnormal movements, and positive symptoms.J Neural Transm. 1989;75(1):1-10. doi: 10.1007/BF01250639. J Neural Transm. 1989. PMID: 2563750
-
Prolactin and psychopathology in schizophrenia: a literature review and reappraisal.Schizophr Res Treatment. 2014;2014:175360. doi: 10.1155/2014/175360. Epub 2014 Mar 27. Schizophr Res Treatment. 2014. PMID: 24800074 Free PMC article. Review.
-
Antipsychotic reduction and/or cessation and antipsychotics as specific treatments for tardive dyskinesia.Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD000459. doi: 10.1002/14651858.CD000459.pub3. Cochrane Database Syst Rev. 2018. PMID: 29409162 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources